Display options
Share it on

Multidiscip Respir Med. 2010 Jun 30;5(3):168-72. doi: 10.1186/2049-6958-5-3-168.

Relationship between disease severity and D-dimer levels measured with two different methods in pulmonary embolism patients.

Multidisciplinary respiratory medicine

Funda Coskun, Dilber Yilmaz, Ahmet Ursavas, Esra Uzaslan, Ercument Ege

Affiliations

  1. Pulmonology Department, School of Medicine, Uludag University, Bursa, Turkey. [email protected].

PMID: 22958319 PMCID: PMC3463048 DOI: 10.1186/2049-6958-5-3-168

Abstract

Pulmonary embolism (PE) is diagnosed with increasing frequency nowadays due to advances in the diagnostic methods and the increased awareness of the disease. There is a tendency to use non invasive diagnostic methods for all diseases. D-dimer is a fibrin degradation product. We aimed to detect the relationship between disease severity and the D-dimer levels measured with two different methods. We compared D-dimer levels in cases of massive vs. non-massive PE. A total of 89 patients who were diagnosed between 2006 and 2008 were included in the study. Group 1 included patients whose D-dimer levels were measured with the immunoturbidimetric polyclonal antibody method (D-dimerPLUS®), while Group 2 patients made use of the immunoturbidimetric monoclonal antibody method (InnovanceD-DIMER®). In each group, the D-dimer levels of those with massive and non-massive PE were compared, using the Mann Whitney U test. The mean age of Group 1 (25 F/26 M) was 56.0 ± 17.9 years, and that of Group 2 (22 F/16 M) was 52.9 ± 17.9 years. There was no statistical difference in gender and mean age between the two groups (p > 0.05). In Group 1, the mean D-dimer level of massive cases (n = 7) was 1444.9 ± 657.9 μg/L and that of nonmassive PE (n = 34) was 1304.7 ± 350.5 μg/L (p > 0.05). In Group 2, the mean D-dimer level of massive cases (n = 6) was 9.7 ± 2.2 mg/L and that of non-massive PE (n = 32) was 5.9 ± 1.3 mg/L (p < 0.05). The mean D-dimer levels of massive cases as measured with the immunoturbidimetric monoclonal antibody method were significantly higher. Pulmonary embolism patients whose D-dimer levels are higher (especially higher than 6.6 mg/L) should be considered as possibly having massive embolism. Diagnostic procedures and management can be planned according to this finding.

References

  1. J Thromb Haemost. 2009 Mar;7(3):391-8 - PubMed
  2. Thromb Haemost. 2001 Dec;86(6):1580-2 - PubMed
  3. J Emerg Med. 2009 Jul;37(1):82-3; author reply 83 - PubMed
  4. Circulation. 2000 Jun 20;101(24):2817-22 - PubMed
  5. Lab Hematol. 2009;15(1):4-9 - PubMed
  6. Thromb Haemost. 1999 Aug;82(2):878-86 - PubMed
  7. Thromb Haemost. 1987 Feb 3;57(1):59-61 - PubMed
  8. J Emerg Med. 2000 Oct;19(3):225-30 - PubMed
  9. Thromb Haemost. 1994 Jan;71(1):1-6 - PubMed
  10. Arch Intern Med. 1991 May;151(5):933-8 - PubMed
  11. Crit Care Med. 2007 Aug;35(8):1937-41 - PubMed
  12. J Thromb Haemost. 2005 Nov;3(11):2465-70 - PubMed
  13. Thromb Res. 2001 Apr 15;102(2):125-31 - PubMed
  14. J Thromb Haemost. 2009 Nov;7(11):1795-801 - PubMed
  15. Arch Intern Med. 2003 Jul 28;163(14):1711-7 - PubMed
  16. J Clin Invest. 1980 Nov;66(5):1033-43 - PubMed
  17. Thromb Res. 2005;115(5):381-6 - PubMed
  18. Blood Coagul Fibrinolysis. 2003 Sep;14(6):545-50 - PubMed
  19. J Emerg Med. 2009 Oct;37(3):290-2 - PubMed
  20. Ann Intern Med. 2004 Apr 20;140(8):589-602 - PubMed
  21. J Thromb Haemost. 2007 Feb;5(2):296-304 - PubMed

Publication Types